Zerion partner submits first European marketing authorisation application
Zerion Pharma said a partner filed a marketing authorisation application in several European countries for a medicinal product formulated with Zerion’s Dispersome® technology. The company said it is the first such regulatory filing.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.